News Feed - US
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation (NYSE: HRT), Checkpoint Therapeutics, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation (NYSE: HRT), Checkpoint Therapeutics, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation (NYSE: HRT), Checkpoint Therapeutics, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of HireRight Holdings Corporation (NYSE: HRT), Checkpoint Therapeutics, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lincoln, Compass Minerals, Exscientia, and Akero and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lincoln National Corporation (NYSE: LNC), Compass Minerals International, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lincoln, Compass Minerals, Exscientia, and Akero and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lincoln National Corporation (NYSE: LNC), Compass Minerals International, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lincoln, Compass Minerals, Exscientia, and Akero and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lincoln National Corporation (NYSE: LNC), Compass Minerals International, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lincoln, Compass Minerals, Exscientia, and Akero and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lincoln National Corporation (NYSE: LNC), Compass Minerals International, Inc....
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Malibu Boats, Equinix, Harbor Diversified, and Altimmune and Encourages Investors to Contact the Firm
– Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Malibu Boats, Inc. (NASDAQ: MBUU), Equinix (NASDAQ: EQIX), Harbor...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Malibu Boats, Equinix, Harbor Diversified, and Altimmune and Encourages Investors to Contact the Firm
– Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Malibu Boats, Inc. (NASDAQ: MBUU), Equinix (NASDAQ: EQIX), Harbor...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Malibu Boats, Equinix, Harbor Diversified, and Altimmune and Encourages Investors to Contact the Firm
– Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Malibu Boats, Inc. (NASDAQ: MBUU), Equinix (NASDAQ: EQIX), Harbor...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Malibu Boats, Equinix, Harbor Diversified, and Altimmune and Encourages Investors to Contact the Firm
– Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Malibu Boats, Inc. (NASDAQ: MBUU), Equinix (NASDAQ: EQIX), Harbor...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of QuidelOrtho Corporation (NASDAQ: QDEL), Perion Network Ltd. (NASDAQ: PERI),...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of QuidelOrtho Corporation (NASDAQ: QDEL), Perion Network Ltd. (NASDAQ: PERI),...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of QuidelOrtho Corporation (NASDAQ: QDEL), Perion Network Ltd. (NASDAQ: PERI),...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of QuidelOrtho Corporation (NASDAQ: QDEL), Perion Network Ltd. (NASDAQ: PERI),...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sharecare, Rivian, GoodRx, and Autodesk and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sharecare, Inc. (NASDAQ: SHCR), Rivian Automotive, Inc. (NASDAQ: RIVN), GoodRx...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sharecare, Rivian, GoodRx, and Autodesk and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sharecare, Inc. (NASDAQ: SHCR), Rivian Automotive, Inc. (NASDAQ: RIVN), GoodRx...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sharecare, Rivian, GoodRx, and Autodesk and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sharecare, Inc. (NASDAQ: SHCR), Rivian Automotive, Inc. (NASDAQ: RIVN), GoodRx...
May 16, 2024 22:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sharecare, Rivian, GoodRx, and Autodesk and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sharecare, Inc. (NASDAQ: SHCR), Rivian Automotive, Inc. (NASDAQ: RIVN), GoodRx...
May 16, 2024 22:00 ET
NEC Leverages RISE with SAP and AI to Build Business AI in Move to the Cloud
WALLDORF, Germany and TOKYO, May 16, 2024 /PRNewswire/ -- SAP SE (NYSE: SAP) today announced NEC Corporation (TSE: 6701 "NEC") has selected SAP S/4HANA Cloud through the RISE with SAP solution, running on Amazon Web Services (AWS). Together with implementation partner ABeam Consulting, the migration will leverage NEC's generative AI technology and SAP's natural language, generative AI Joule copilot.
May 16, 2024 21:20 ET
Class Action Filed Against Rivian Automotive, Inc. (RIVN) - June 18, 2024 Deadline to Join – Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your Rivian Automotive, Inc. (NASDAQ:RIVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
May 16, 2024 21:15 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 21:10 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PowerSchool Holdings, Inc. - PWSC
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PowerSchool Holdings, Inc. ("PowerSchool" or the "Company") (NYSE: PWSC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 21:05 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Primerica, Inc. - PRI
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") (NYSE: PRI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 21:01 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 20:55 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. - RVPH
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") (NASDAQ: RVPH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980
May 16, 2024 20:50 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Jabil Inc. - JBL
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Jabil Inc. ("Jabil" or the "Company") (NYSE: JBL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 20:47 ET
Class Action Filed Against The Chemours Company (CC) - May 20, 2024 Deadline to Join – Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
May 16, 2024 20:45 ET
Bolt Biotherapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Bolt Biotherapeutics, Inc. (BOLT)
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bolt Biotherapeutics, Inc. ("Bolt Biotherapeutics, Inc.") (NASDAQ:BOLT) concerning possible violations of federal securities laws.
May 16, 2024 20:45 ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 15, 2024 in UnitedHealth Group Inc. Lawsuit - UNH
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your UnitedHealth Group Inc. (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
May 16, 2024 20:45 ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2024 in The Chemours Company Lawsuit – CC
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
May 16, 2024 20:45 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ: ABEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 20:35 ET
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Agrify Corporation - AGFY
NEW YORK, May 16, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and is investigating Agrify Corporation (NASDAQ: AGFY), relating to its proposed merger with Nature's Miracle Holding Inc. Under the terms of the agreement, Agrify shareholders will each be issued 0.45 of a share of Nature's Miracle common stock for each share of Agrify common stock that the
May 16, 2024 20:32 ET
PreveCeutical Provides Update on Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect to the Management Cease Trade Order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), effective as of May 2, 2024, and as previously announced by the Company.
May 16, 2024 20:30 ET
INVESTIGATION: The M&A Class Action Firm Announces An Investigation of SilverBow Resources, Inc. - SBOW
NEW YORK, May 16, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and is investigating SilverBow Resources, Inc. (NYSE: SBOW), relating to its proposed merger with Crescent Energy Company. Under the terms of the agreement, SilverBow shareholders will receive 3.125 shares of Crescent Class A common stock for each share of SilverBow common stock, with the op
May 16, 2024 20:30 ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 15, 2024 in UnitedHealth Lawsuit – UNH
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your UnitedHealth Group Inc. (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
May 16, 2024 20:30 ET
ROSEN, A RANKED AND LEADING FIRM, Encourages Rivian Automotive, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RIVN
NEW YORK, May 16, 2024 /PRNewswire/ --
May 16, 2024 20:30 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hertz Global Holdings, Inc. - HTZ
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hertz Global Holdings, Inc. ("Hertz" or the "Company") (NASDAQ: HTZ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 20:22 ET
GoldMining Announces Voting Results
VANCOUVER, BC, May 16, 2024 /CNW/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE: GLDG) is pleased to announce that at its annual general meeting held on May 16, 2024 (the "Meeting"), all nominees listed in its management information circular dated March 25, 2024 were elected as directors of the Company.
May 16, 2024 20:22 ET
GoldMining Announces Voting Results
VANCOUVER, BC, May 16, 2024 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE: GLDG) is pleased to announce that at its annual general meeting held on May 16, 2024 (the "Meeting"), all nominees listed in its management information circular dated March 25, 2024 were elected as directors of the Company.
May 16, 2024 20:15 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avid Bioservices, Inc. ("Avid" or the "Company") (NASDAQ: CDMO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 20:02 ET
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced it has entered into exclusive...
May 16, 2024 20:01 ET
Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds The Chemours Company Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm (CC)
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) (“Chemours” or the “Company”) on behalf of investors who purchased or...
May 16, 2024 20:01 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arhaus, Inc. - ARHS
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. ("Arhaus" or the "Company") (NASDAQ: ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 20:00 ET
Erasca Announces Pricing of Underwritten Offering of Common Stock
Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an underwritten...
May 16, 2024 20:00 ET
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new and updated data related to novel investigational hematological...
May 16, 2024 20:00 ET
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sonder Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SOND
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sonder Holdings Inc. (NASDAQ: SOND) between March 16, 2023 and March 15, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2024...
May 16, 2024 20:00 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeutics, Inc. - BOLT
NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ: BOLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 16, 2024 19:57 ET
Genco Shipping & Trading Issues Statement Regarding George Economou’s Withdrawal of his Nominee
Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”) the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today issued the following statement regarding George Economou’s withdrawal...
News Release Providers
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.